Group 1 - The core viewpoint of the news highlights the recent performance and financial metrics of Jiuzhou Pharmaceutical, including stock price movements and trading volumes [1][2] - As of September 29, Jiuzhou Pharmaceutical's stock price increased by 2.06%, reaching 19.32 CNY per share, with a total market capitalization of 17.184 billion CNY [1] - The company has seen a year-to-date stock price increase of 46.52%, with a 1.68% rise over the last five trading days and a 28.87% increase over the last 60 days [1] Group 2 - Jiuzhou Pharmaceutical's main business revenue composition includes 79.81% from new drug custom development and production services (CDMO), 18.22% from specialty raw materials and intermediates, and 1.96% from other sources [1] - For the first half of 2025, Jiuzhou Pharmaceutical reported a revenue of 2.871 billion CNY, reflecting a year-on-year growth of 3.86%, and a net profit attributable to shareholders of 526 million CNY, up 10.70% [2][3] - The company has distributed a total of 2.183 billion CNY in dividends since its A-share listing, with 1.245 billion CNY distributed in the last three years [3]

Core Viewpoint - Huahai Pharmaceutical's stock has experienced fluctuations, with a year-to-date increase of 15.77% but a recent decline over various trading periods, indicating potential volatility in the market [1][2]. Financial Performance - For the first half of 2025, Huahai Pharmaceutical reported revenue of 4.516 billion yuan, a year-on-year decrease of 11.93%, and a net profit attributable to shareholders of 409 million yuan, down 45.30% year-on-year [2]. - Cumulative cash dividends since the company's A-share listing amount to 2.989 billion yuan, with 1.016 billion yuan distributed over the past three years [3]. Stock Market Activity - As of September 29, Huahai Pharmaceutical's stock price was 20.40 yuan per share, with a market capitalization of 30.544 billion yuan [1]. - The stock has seen significant trading activity, with a net inflow of 363,300 yuan from main funds and notable buying and selling volumes over recent days [1]. Shareholder Information - As of September 19, the number of shareholders increased by 28.47% to 67,300, while the average circulating shares per person decreased by 22.16% to 21,624 shares [2]. - Major shareholders include China Europe Medical Health Mixed A, which increased its holdings by 12.234 million shares, and Southern CSI 500 ETF, which also saw an increase in holdings [3].

Company Overview - Shuyou Shen (Beijing) Biopharmaceutical Co., Ltd. is primarily engaged in the research, production, and sales of biological products and some chemical drugs, with a significant revenue contribution from injectable nerve growth factor (Sutai) at 59.17% and compound polyethylene glycol electrolyte powder at 33.19% [1][2] Stock Performance - As of September 29, Shuyou Shen's stock price decreased by 2.10% to 33.16 CNY per share, with a total market capitalization of 15.843 billion CNY [1] - The stock has seen a year-to-date increase of 347.50%, but has declined by 8.68% over the last five trading days, 38.43% over the last 20 days, and 24.84% over the last 60 days [1] Financial Performance - For the first half of 2025, Shuyou Shen reported a revenue of 126 million CNY, a year-on-year decrease of 31.14%, and a net profit attributable to shareholders of -24.636 million CNY, a decline of 619.70% [2] Shareholder Information - As of June 30, 2025, the number of shareholders increased by 29.20% to 31,700, with an average of 14,327 shares per shareholder, down by 22.60% [2] - The company has cumulatively distributed 771 million CNY in dividends since its A-share listing, with no dividends paid in the last three years [3] Institutional Holdings - Notable new institutional shareholders include Xingquan He Run Mixed A, holding 15.721 million shares, and several other funds, indicating a shift in shareholder composition [3]

陈铁军强调，站在新的历史起点，期待深圳分会做"产业报国"的先行者，以全球视野抢滩新材料、人工 智能、生物医药等未来赛道，让"赫山智造"闪耀湾区、对话世界。当"反哺桑梓"的排头兵，聚焦现代农 业、文旅融合、数字经济等家乡所需，带着项目回归、携着技术扎根，让游子情怀化作振兴力量。 成"改革创新"的智囊团，将深圳理念、湾区经验转化为发展良策，为赫山深化产业革新、优化营商环 境、建设人才高地注入智慧动能。 大会对赫山区经促会深圳分会新一届领导班子及成员进行了授牌。新任会长方建辉就如何做好分会工作 作了表态。 陈铁军代表赫山区政协、赫山经促会，向新一届理事会成员致以热烈的祝贺。他指出，经促会作为政协 团结乡友、汇聚资源的重要平台，始终秉持"凝聚乡情、汇聚资源、服务发展"的宗旨，深植"独行快、 众行稳"的抱团理念。此次深圳分会换届，不仅是服务赫山发展的新起点，更是乡友共同体的再升华， 新一代赫商将以聚沙成塔的合力，共拓家乡振兴的康庄大道。 9月27日下午，赫山区经促会深圳分会换届大会在深圳举行。市人大常委会党组成员、副主任，赫山区 委书记周卫星，区委副书记、区长李丰出席，区政协党组书记、主席陈铁军致辞，区政协党组副书记、 ...

Market Review - The A-share market experienced overall fluctuations this week, with major indices showing mixed performance. The semiconductor industry chain strengthened significantly, with the Sci-Tech 50 Index rising by 6.47%, driven by increased capital expenditure in the AI sector and breakthroughs in domestic lithography technology. Conversely, the consumer sector weakened, with indices in social services, retail, light industry, and textiles showing the largest declines. Market turnover decreased marginally, with net inflows of financing funds maintained, and stock ETFs saw a net subscription of 231 billion yuan this week. In the commodity market, internationally priced commodities strengthened, while domestically priced black commodities declined. The dollar index rose, with the 10-year U.S. Treasury yield returning to around 4.2%, and the RMB depreciated against the dollar [1][2]. Market Outlook - The A-share and Hong Kong stock markets are expected to experience temporary fluctuations, with a "slow bull" market continuing. After a trend-driven rise in July and August, funding divergence has increased since September. With the upcoming long holiday, external funds entering the market may slow down, leading to potential short-term adjustments in both markets. However, the current bull market is still in play, supported by ample micro liquidity, policies aimed at stabilizing the stock market, and long-term capital inflows. Despite weak economic data, the effects of "anti-involution" policies are beginning to show, leading to marginal improvements in long-term profit expectations for A-shares. Key areas of focus include: - The technology sector remains the main focus, with both "prosperity investment" and "thematic investment" expected to coexist in October. Internal rotation within growth sectors is anticipated to accelerate, particularly in AI downstream applications, solid-state batteries, energy storage, computing power, and innovative pharmaceuticals. Attention should also be given to non-tech sectors showing positive trends, such as chemicals, non-ferrous metals, and engineering machinery [2][3]. International Perspective - On the international front, the Federal Reserve's "preventive" interest rate cuts have been implemented, but there is increasing divergence regarding future rate cut paths. In September, the Fed cut rates by 25 basis points as expected, with projections indicating a potential further reduction of 50 basis points within the year. However, there is significant disagreement among Fed officials regarding future cuts, with 9 out of 19 officials expecting two more cuts in 2025, while others foresee no further reductions. Current U.S. economic data remains resilient, and Fed Chair Powell's cautious signals regarding rate cuts suggest a potentially complicated path ahead [3]. Supply-Side Policies - The impact of supply-side "anti-involution" policies is gradually becoming evident, with industrial profits rebounding in August. Year-on-year growth in industrial profits for August was 20.4%, improving from a -1.7% decline in July to a cumulative growth of 0.9%. The Producer Price Index (PPI) saw a narrowing decline of -2.9% year-on-year, marking the first contraction since March. This improvement is attributed to a low base effect and the gradual impact of supply-side policies, which have led to price increases in upstream commodities. The central bank has emphasized the challenges of insufficient domestic demand and low price levels, with recent policies aimed at boosting prices being implemented [3]. Structural Trends - In terms of structure, the technology sector is experiencing numerous catalysts, with high growth expectations for TMT (Technology, Media, and Telecommunications) sectors. The new wave of technological advancements driven by AI is accelerating across various fields. Key factors include the increasing clarity of domestic and international AI industry trends, rapid growth in the performance of leading companies, and a focus on hard technology and new production capabilities in upcoming policy meetings. Market consensus on profit expectations indicates high growth for growth sectors in 2025, including military electronics, software development, IT services, optical electronics, gaming, new energy, semiconductors, and communication equipment [3]. Liquidity Conditions - The liquidity situation in the A-share market remains ample. In August, non-bank deposits increased by 550 billion yuan year-on-year, and the M1-M2 negative differential continues to narrow, reflecting a positive impact on residents' risk appetite. Unlike the previous "structural bull" market from 2019 to 2021, where residents favored active funds, this bull market sees a preference for passive investment products. Since the fourth quarter of 2024, the net asset value of stock ETFs has rapidly expanded, with index funds consistently outpacing active equity funds for three consecutive quarters, further promoting the trend towards indexation in the industry. The central bank's monetary policy remains moderately accommodative, with funding rates trending downward and bank wealth management products yielding historically low returns, suggesting that micro liquidity in the A-share market is likely to remain ample in the fourth quarter [3].

湖南此次赴沪揽才，精准把握了当前人才市场的"供需关系"。从需求端看，众多岗位聚焦新一代信息技 术、先进制造、生物医药等领域——恰好与上海高校在集成电路、人工智能、生命科学等学科的优势高 度契合；从供给端看，湖南不只是给岗位，更注重"搭平台""优环境"："1+2"国家实验室体系、"4+4科 创工程"提供一流科研载体，职称评审破"四唯"，"最具幸福感城市"的生态又解决了生活后顾之忧。这 一套"产业有赛道、科研有支撑、生活有保障"的组合拳，向在沪学子展示了一张张充满机遇的"青春船 票"。 在复旦大学公共卫生专业就读的唐同学即将毕业，她表示这是第一次参加这么大型的招聘会，湖南带着 满满的诚意前来，让她感受到了人才被尊重，被爱护和被重视。"希望能够在这次招聘会上找到心仪的 岗位。" 现场，湖南省与复旦大学、上海交通大学、同济大学、华东师范大学签署合作协议，共同开启省校合作 新篇章。接下来，省校双方将立足"湖南所需"和"高校所能"，重点关注线上或点上可具象、可操作、可 落地的合作场景，以产业合作为主体，以科技、教育合作为补充，聚焦人工智能、量子计算、航空航 天、生物医药等领域开展深度合作，实现优势互补、良性互动，力争打造 ...

9 月 25 日， 2025 （第十九届） DEMO CHINA 在杭州圆满落幕。 本届大会由创业邦主办，由杭 州市拱墅区人民政府指导，拱墅区委人才办、杭州大运河数智未来城管委会联合主办。 作为早期创业者被看见和被发现的最佳平台 ， 本届大会共吸引 590 余家企业报名，经过层层筛选， 126 家早期科技公司成功入围。大会现场，机器人 *智能硬件、人工智能创新应用、智能制造、医疗 科技以及高通创投 - 红杉中国创业大赛、海外人才等六大专场，为我 们带来硬核技术与前瞻商业构 想的集中呈现。 从初选到现场评审， DEMO CHINA 始终秉持 " 科学严谨 " 和 " 前 瞻视野 " 的原则，综合考量团 队背景、商业模式、产品服务、市场吸引力、运营状况、创新力及现场表现力等维度进行严格筛选。 参与展示的企业，平均成立时间仅有 2.76 年，均处于 A 轮及 A 轮前期，其中更有 16% 为尚未被 主流风险投资发现的 " 水下公司 " 。值得关注的是，这些企业创始人中硕士及以上占比高达 89% ，博士及博士后占比 65% ，超半数团队拥有海外经历，高知背景与国际视野成为早期科创团队的核 心底色。 大会现场， 经过多 ...

9月26日，市委书记周红波会见了由港区省级政协委员联谊会主席苏清栋、会长霍启山率领的考察 团一行，市政协主席王立平出席。 市委常委、统战部部长吴勇强参加。 港区省级政协委员联谊会是爱国爱港的重要力量，既是政协委员的联谊之家，也是宁港交流合作的 重要纽带。会见中，双方表示要共同落实粤港澳大湾区建设和长三角一体化发展战略，持续拓展宁港经 贸合作空间，扩大高水平对外开放，进一步密切人文等方面交流，推动宁港两地协同发展。要在科技创 新、金融服务、生物医药、文旅消费等领域帮助南京扩大朋友圈，助力南京企业"走出去"，带动更多港 商、港资和青年人才选择南京、投资南京。 ...

南方都市报、南都大数据研究院"信心有数"栏目，用数据记录广东实现现代化的奋进之路，用数据描绘 万马奔腾共创美好的活力之路，用数据书写每一个你我昂扬向上的信心之路。 千里之行，系于你我；心中有数，广东可期。 四海粤商，接帖集结！2025世界粤商大会定于9月28日至30日举行。届时，超1387亿资本将强势汇聚， 36个超十亿级项目将进行现场签约。全球粤商精英天团即将齐聚广州，共赴这场商界"武林盛会"！南都 大数据研究院本期"信心有数"带你提前看：这场盛会的"雄厚家底"与粤商群体的强劲实力。 粤商大会"粤"联四海 历经7届越办越有料 "信心有数"栏目 广东民企不仅在"大"，更胜在"活"和"新"。9月15日公布的2025中国企业500强榜单中，广东有54家企业 上榜，其中半数以上为民营企业。华为、腾讯、比亚迪等企业不仅在国内市场表现优异，更在全球创新 竞赛中实现从"跟跑"到"并跑"乃至"领跑"的转变。华为上半年研发投入969.5亿元，占营收22.7%；比亚 迪研发投入309亿元，同比增长53%；腾讯累计专利授权超4.6万项…… 这些成绩的背后，离不开广东对的"政策护航"。中华人民共和国民营经济促进法》今年施行后，广东 ...

目前，上海形成需求、招生、培养、就业和监测联动机制，开展全市高校毕业生就业状况全口径、 长周期调研工作。当天，教育部高校学生司（高校毕业生就业服务司）向沪上高校授牌"上海市高校毕 业生跟踪调查分中心"。 为破解结构性就业矛盾，补齐学生技能短板，上海正积极推进职前培训体系建设，研习坊成为大学 生职前实践的"练兵场"。在现场，一批用人单位向2025年上海大学生职前见习坊毕业生代表颁发证书。 上海市副市长解冬等出席并宣布招聘会启动。 记者 徐瑞哲 昨天，2026届上海高校毕业生秋季校园招聘会暨长三角联合招聘会在上海交通大学闵行校区霍英东 体育中心举行，超过1000家用人单位进场招聘新一届毕业学子，共提供用人需求3.5万个，涵盖集成电 路、生物医药、人工智能等多个重点产业，实现"一地参会、岗通长三角"。 据悉，教育部门预估全市应届生源的情况显示，明年上海高校毕业生预计规模达25.8万人，其中研 究生9.1万人、本科生11.3万人、专科高职学生5.4万人。 ...